{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:40:00Z","timestamp":1789123200782,"version":"build-2803163510"},"reference-count":41,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,11,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic aberrations, including trisomies 3 and 18, and well-defined IGH translocations, have been described in marginal zone lymphomas (MZLs); however, these known genetic events are present in only a subset of cases. Here, we report the cloning of an IGH translocation partner on chromosome X, t(X;14)(p11.4;q32) that deregulates expression of an poorly characterized orphan G-protein\u2013coupled receptor, GPR34. Elevated GPR34 gene expression was detected independent of the translocation in multiple subtypes of non-Hodgkin lymphoma and distinguished a unique molecular subtype of MZL. Increased expression of GPR34 was also detected in tissue from brain tumors and surface expression of GPR34 was detected on human MZL tumor cells and normal immune cells. Overexpression of GPR34 in lymphoma and HeLa cells resulted in phosphorylation of ERK, PKC, and CREB; induced CRE, AP1, and NF-\u03baB\u2013mediated gene transcription; and increased cell proliferation. In summary, these results are the first to identify a role for a GPR34 in lymphoma cell growth, provide insight into GPR34-mediated signaling, identify a genetically unique subset of MZLs that express high levels of GPR34, and suggest that MEK inhibitors may be useful for treatment of GPR34-expressing tumors.<\/jats:p>","DOI":"10.1182\/blood-2011-11-389908","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T06:14:44Z","timestamp":1347344084000},"page":"3949-3957","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":51,"title":["t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth"],"prefix":"10.1182","volume":"120","author":[{"given":"Stephen M.","family":"Ansell","sequence":"first","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akasaka","sequence":"additional","affiliation":[{"name":"MRC Toxicology Unit, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"McPhail","sequence":"additional","affiliation":[{"name":"Divisions of Hematopathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Manske","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Braggio","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Scottsdale, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Price-Troska","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ziesmer","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Secreto","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Scottsdale, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Law","sequence":"additional","affiliation":[{"name":"Divisions of Hematopathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J. S.","family":"Dyer","sequence":"additional","affiliation":[{"name":"MRC Toxicology Unit, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Anatomic Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Novak","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111808052325400_B1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V96.3.808","article-title":"The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies.","volume":"96","author":"Willis","year":"2000","journal-title":"Blood"},{"issue":"18","key":"2019111808052325400_B2","first-page":"3944","article-title":"The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.","volume":"57","author":"Ott","year":"1997","journal-title":"Cancer Res"},{"issue":"10","key":"2019111808052325400_B3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1023\/A:1008202303666","article-title":"t(11;18)(q21;q21) is the most common translocation in MALT lymphomas.","volume":"8","author":"Auer","year":"1997","journal-title":"Ann Oncol"},{"issue":"5","key":"2019111808052325400_B4","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood.V74.5.1796.1796","article-title":"Four new recurring translocations in non-Hodgkin lymphoma.","volume":"74","author":"Levine","year":"1989","journal-title":"Blood"},{"issue":"1","key":"2019111808052325400_B5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","article-title":"Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.","volume":"96","author":"Willis","year":"1999","journal-title":"Cell"},{"issue":"6","key":"2019111808052325400_B6","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma.","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111808052325400_B7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"issue":"2","key":"2019111808052325400_B8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3324\/haematol.2011.052639","article-title":"t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34.","volume":"97","author":"Baens","year":"2012","journal-title":"Haematologica"},{"issue":"8","key":"2019111808052325400_B9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc1409","article-title":"MALT lymphoma: from morphology to molecules.","volume":"4","author":"Isaacson","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2019111808052325400_B10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(01)00189-1","article-title":"Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.","volume":"104","author":"Ruland","year":"2001","journal-title":"Cell"},{"issue":"9","key":"2019111808052325400_B11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni963","article-title":"Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells.","volume":"4","author":"Xue","year":"2003","journal-title":"Nat Immunol"},{"issue":"22","key":"2019111808052325400_B12","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M009984200","article-title":"Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.","volume":"276","author":"Lucas","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111808052325400_B13","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/sj.leu.2403500","article-title":"Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.","volume":"18","author":"Sonoki","year":"2004","journal-title":"Leukemia"},{"issue":"8","key":"2019111808052325400_B14","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2006-08-041012","article-title":"Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).","volume":"109","author":"Akasaka","year":"2007","journal-title":"Blood"},{"issue":"12","key":"2019111808052325400_B15","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.pas.0000213275.60962.2a","article-title":"The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.","volume":"30","author":"Remstein","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2019111808052325400_B16","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-08-3701","article-title":"Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.","volume":"69","author":"Braggio","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"2019111808052325400_B17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cmb.2006.13.215","article-title":"Efficient calculation of interval scores for DNA copy number data analysis.","volume":"13","author":"Lipson","year":"2006","journal-title":"J Comput Biol"},{"issue":"3","key":"2019111808052325400_B18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood-2008-02-140996","article-title":"Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications.","volume":"113","author":"Chng","year":"2009","journal-title":"Blood"},{"issue":"36","key":"2019111808052325400_B19","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111808052325400_B20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.","volume":"9","author":"Lee","year":"2006","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111808052325400_B21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1182\/blood-2009-07-234799","article-title":"Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.","volume":"115","author":"Suryani","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111808052325400_B22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data.","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"issue":"2","key":"2019111808052325400_B23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygeno.2005.10.001","article-title":"Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34.","volume":"87","author":"Engemaier","year":"2006","journal-title":"Genomics"},{"issue":"1-2","key":"2019111808052325400_B24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0167-4781(99)00081-0","article-title":"A novel subgroup of class I G-protein-coupled receptors.","volume":"1446","author":"Sch\u00f6neberg","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2019111808052325400_B25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbrc.2006.01.069","article-title":"Identification of a lysophosphatidylserine receptor on mast cells.","volume":"341","author":"Sugo","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"37","key":"2019111808052325400_B26","doi-asserted-by":"crossref","first-page":"35531","DOI":"10.1074\/jbc.M303346200","article-title":"The structural evolution of a P2Y-like G-protein-coupled receptor.","volume":"278","author":"Schulz","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111808052325400_B27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0026-895X(25)10025-4","article-title":"An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.","volume":"45","author":"Zhu","year":"1994","journal-title":"Mol Pharmacol"},{"issue":"7","key":"2019111808052325400_B28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nat Med"},{"issue":"2","key":"2019111808052325400_B29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc2069","article-title":"G-protein-coupled receptors and cancer.","volume":"7","author":"Dorsam","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2019111808052325400_B30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1471-4892(02)00214-X","article-title":"Receptor classification: post genome.","volume":"2","author":"Foord","year":"2002","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"2019111808052325400_B31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors.","volume":"3","author":"Pierce","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2019111808052325400_B32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-1119(01)00651-5","article-title":"Discovery and mapping of ten novel G protein-coupled receptor genes.","volume":"275","author":"Lee","year":"2001","journal-title":"Gene"},{"issue":"1","key":"2019111808052325400_B33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/geno.1998.5655","article-title":"Discovery of three novel orphan G-protein-coupled receptors.","volume":"56","author":"Marchese","year":"1999","journal-title":"Genomics"},{"key":"2019111808052325400_B34","article-title":"Altered immune response in mice deficient for the G protein-coupled receptor GPR34.","author":"Liebscher","year":"2010","journal-title":"J Biol Chem"},{"issue":"11","key":"2019111808052325400_B35","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/sj.embor.7400838","article-title":"Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers.","volume":"7","author":"Levoye","year":"2006","journal-title":"EMBO Rep"},{"issue":"7","key":"2019111808052325400_B36","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","article-title":"GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.","volume":"69","author":"Thangaraju","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"2019111808052325400_B37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cytogfr.2006.09.009","article-title":"Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.","volume":"17","author":"Migeotte","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"2019111808052325400_B38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1073\/pnas.0601947103","article-title":"CARMA3\/Bcl10\/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.","volume":"104","author":"McAllister-Lucas","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111808052325400_B39","doi-asserted-by":"crossref","first-page":"e21382","DOI":"10.1371\/journal.pone.0021382","article-title":"Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications.","volume":"6","author":"Vegliante","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"2019111808052325400_B40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2019111808052325400_B41","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/19\/3949\/1359513\/zh804512003949.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/19\/3949\/1359513\/zh804512003949.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T05:49:21Z","timestamp":1744091361000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/19\/3949\/30675\/tX14p11q32-in-MALT-lymphoma-involving-GPR34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,8]]},"references-count":41,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,11,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-11-389908","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,8]]}}}